| Company Name: |
Zhengzhou Granlen Sciences, ltd.
|
| Tel: |
0371-85513397 +86-18610099868 |
| Email: |
info@granlen.com |
| Products Intro: |
Product Name:3’,5’-di-O-benzoyl thymidine
CAS:35898-30-7
Purity: 95% HPLC Package:根据客户需要包装 Remarks:GL103297
|
3',5'-DI-O-BENZOYLTHYMIDINE manufacturers
|
| | 3',5'-DI-O-BENZOYLTHYMIDINE Basic information |
| Product Name: | 3',5'-DI-O-BENZOYLTHYMIDINE | | Synonyms: | 3',5'-DI-O-BENZOYLTHYMIDINE;thymidine 3',5'-dibenzoate;3'-O,5'-O-Dibenzoylthymidine;benzoic acid [(2R,3S,5R)-3-benzoyloxy-5-(5-methyl-2,4-dioxo-1-pyrimidinyl)-2-oxolanyl]methyl ester;3’,5’-di-O-benzoylthymidine | | CAS: | 35898-30-7 | | MF: | C24H22N2O7 | | MW: | 450.44 | | EINECS: | 2527861 | | Product Categories: | | | Mol File: | 35898-30-7.mol |  |
| | 3',5'-DI-O-BENZOYLTHYMIDINE Chemical Properties |
| | 3',5'-DI-O-BENZOYLTHYMIDINE Usage And Synthesis |
| Uses | 3’,5’-Di-O-benzoyl thymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 3',5'-DI-O-BENZOYLTHYMIDINE Preparation Products And Raw materials |
|